Ergoteles LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q3 2022$386,000
+56.3%
19,943
+140.6%
0.01%
+55.6%
Q1 2022$247,0008,2880.01%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Prosight Management, LP 491,244$9,510,0005.10%
Decheng Capital Management III (Cayman), LLC 623,342$12,068,0004.38%
TANG CAPITAL MANAGEMENT LLC 1,099,516$21,287,0002.61%
Privium Fund Management B.V. 300,252$5,624,0002.04%
Birchview Capital, LP 117,000$2,265,0001.60%
Perceptive Advisors 2,360,139$45,692,0001.33%
Chicago Capital, LLC 1,119,774$21,679,0001.25%
Endurant Capital Management LP 172,621$3,342,0001.09%
Deep Track Capital, LP 1,110,624$21,502,0000.98%
SPHERA FUNDS MANAGEMENT LTD. 359,000$6,950,0000.96%
View complete list of ALBIREO PHARMA INC shareholders